Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant PR Newswire EDINBURGH, Scotland, Nov. 12, 2024 EDINBURGH, Scotland, Nov. 12, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...
TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements PR Newswire EDINBURGH, Scotland, Oct. 30, 2024 EDINBURGH, Scotland, Oct. 30, 2024 /PRNewswire/ -- TC BioPharm...
TCBP Responds to False Social Media Claim PR Newswire EDINBURGH, Scotland, Oct. 25, 2024 TC BioPharm remains compliant with all Nasdaq listing requirements and will continue trading on the...
TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic PR Newswire EDINBURGH, Scotland, Oct. 22, 2024 EDINBURGH, Scotland, Oct. 22, 2024 /PRNewswire/...
TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...
TCBP Announces Site Opening of Guys and St. Thomas Hospital PR Newswire EDINBURGH, Scotland, Sept. 25, 2024 Additional London-based clinic to increase enrolment velocityLeading hospital with...
TCBP to Present at the 2024 ThinkEquity Conference in NYC PR Newswire EDINBURGH, Scotland, Sept. 24, 2024 EDINBURGH, Scotland, Sept. 24, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...
/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 In the news release, TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial...
TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 No TCB008-related Adverse Events seen in any of the re-start...
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 9, 2024 EDINBURGH, Scotland, Sept. 9, 2024 /PRNewswire/ -- TC BioPharm...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
